Evaluation of end-of-Life chemotherapy: a medical and economic challenge revealed by a retrospective observational study.

ABSTRACT:

Purpose

The continuation or discontinuation of oncological care is a critical consideration, particularly due to its implications for quality of life at the end of life. We evaluated the management of cancer patients during the final 90 days of life by measuring the intensity of care and assessing its overall impact.

Method

Characterize care pathways and patient status during the last 90 days of life, including a survival analysis based on Charlson and BARBOT (Pronopall) scores. Care intensity was evaluated using a composite score based on hospitalizations, emergency visits, and ICU admissions. We also compared chemotherapy-treated and untreated patients in terms of survival, care intensity, polypharmacy, and healthcare resource use, focusing on hospitalization and chemother

SUBMITTER: Agius P 

PROVIDER: S-EPMC12380927 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature